Business Overview

The Piramal Critical Care business of Piramal Healthcare Limited markets a wide range of important hospital and life saving pharmaceuticals which include Inhalation and Intravenous Anesthetics, Plasma Volume Expanders and Muscle Relaxants.

With an aim to emerge as a global leader in this segment, we embarked upon a string of Mergers & Acquisitions:

• Rhodia (Inhalation Anesthesia Business), UK in FY2005
• PlasmaSelect AG (Haemaccel Business), Germany in FY2008
• Minrad Inc. and RxElite Holdings, US in FY2009
• Bharat Serums and Vaccines Limited (Anesthesia Business), India in FY 2010

These strategic alliances have been consistent with the objective of recognizing the compelling potential of our critical care business and emerging as a leading player in this segment.

Our key customers include Group Purchasing Organizations (GPO’s), Human and Veterinary Hospitals, Surgery Centers, Anesthesiologists, Intensivists, University Research Centers and Medical Industry.